FDA Inspection
Padagis Israel Pharmaceuticals Ltd.Padagis Israel Pharmaceuticals Ltd. – FDA Inspection, Oct 27, 2022
Record Details
This FDA Inspection record concerns Padagis Israel Pharmaceuticals Ltd., with an inspection on October 27, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 27, 2022
- Product Type
- Drugs
View Company Profile
ID · 37421244-ea78-44bd-98ce-93597e9687f4
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1191880
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Padagis Israel Pharmaceuticals Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2023 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 13, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 27, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Padagis Israel Pharmaceuticals Ltd.
- FDA Inspection 1220679 - 2023-09-20
- FDA Inspection 1099381 - 2019-06-13
- FDA Inspection 1065389 - 2018-07-19
- FDA Inspection 910286 - 2015-01-22
- FDA Inspection 837639 - 2012-08-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.